戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rium avium complex (MAC) and 69 (36%) for M. abscessus.
2 bserved in M. marinum and the smallest in M. abscessus.
3 of a series of indolecarboxamides against M. abscessus.
4 ycobacteria including M. tuberculosis and M. abscessus.
5 topic shifts from incorporation of 15N in M. abscessus.
6 enum varied from those of M. chelonae and M. abscessus.
7 solates of M. chelonae and 25 isolates of M. abscessus.
8 t distinguish Mycobacterium chelonae from M. abscessus.
9 ne sequencing to identify M. chelonae and M. abscessus.
10 tiate M. immunogenum from M. chelonae and M. abscessus.
11 ting that this clone is a subgroup within M. abscessus.
12 erial species Mycobacterium fortuitum and M. abscessus.
13     The isolates were later identified as M. abscessus.
14 ers Mycobacterium smegmatis or Mycobacterium abscessus.
15  occur during chronic lung infection with M. abscessus.
16  20% of U.S. isolates of M. abscessus subsp. abscessus.
17  erm(41) genotype is a useful adjunct for M. abscessus.
18 table to test antibiotic activity against M. abscessus.
19 showed promising in vivo activity against M. abscessus.
20 which we propose the name "Para-streptomyces abscessus."
21 l isolates identified 2 clonal strains of M. abscessus; 1 clone was isolated from water sources at a
22 acterized clinical isolates comprising 29 M. abscessus, 15 M. massiliense, and 2 M. bolletii isolates
23 terium avium complex (72%) and Mycobacterium abscessus (16%) were the most common species.
24 or rapidly growing mycobacteria (98% were M. abscessus), 78% (29 of 37) for M. kansasii, and 26% (9 o
25           Lung infections with Mycobacterium abscessus, a species of multidrug-resistant nontuberculo
26 iduals with cystic fibrosis (CF), in whom M. abscessus accelerates inflammatory lung damage, leading
27 alues for 81 isolates of M. abscessus subsp. abscessus and 12 isolates of M. abscessus subsp. massili
28 identified 41 Mycobacterium abscessus subsp. abscessus and 13 M. abscessus subsp. massiliense isolate
29                A total of 82 isolates (58 M. abscessus and 24 M. chelonae isolates) were tested blind
30 hods, 46 of the isolates were found to be M. abscessus and 29 were identified as M. chelonae.
31                 erm(41) sequencing of 285 M. abscessus and 45 M. chelonae isolates was compared to 14
32 l sequencing) is required for division of M. abscessus and closely related species.
33 of two clonal groups for M. abscessus subsp. abscessus and five clonal groups for M. abscesssus subsp
34 reviously identified as being M. chelonae/M. abscessus and identified M. massiliense from isolates fr
35 g of M. fortuitum against clarithromycin; M. abscessus and M. chelonae against the aminoglycosides; a
36 ld be able to easily identify isolates of M. abscessus and M. chelonae.
37 may be helpful for distinguishing between M. abscessus and M. chelonae.
38 enome, regions that discriminated between M. abscessus and M. massiliense were identified through arr
39 d three pairs of closely related strains: M. abscessus and M. massiliense, M. mucogenicum and M. phoc
40                                Mycobacterium abscessus and Mycobacterium chelonae are two closely rel
41 rly for distinguishing between Mycobacterium abscessus and Mycobacterium chelonae.
42 olates were typed as M. abscessus subspecies abscessus and were clonally related within each patient.
43 oscopes and endoscopic cleaning machines (M. abscessus) and contaminated hospital water supplies (M.
44 tes of N. cyriacigeorgica, N. asteroides, N. abscessus, and N. otitidiscaviarum were susceptible to t
45 bmitted as M. chelonae were identified as M. abscessus, and one isolate submitted as M. abscessus was
46 cterium fortuitum group, three Mycobacterium abscessus, and three Mycobacterium chelonae isolates) we
47 rium fortuitum group, three of Mycobacterium abscessus, and three of Mycobacterium chelonae) were tes
48 bacterial infections caused by Mycobacterium abscessus are responsible for a range of disease manifes
49 metic mean = 1.5% of hsp65 sequences) and M. abscessus (arithmetic mean = 0.006% of hsp65 sequences).
50 tigated a biphasic outbreak of Mycobacterium abscessus at a tertiary care hospital.
51                              Based on the M. abscessus ATCC 19977(T) genome, regions that discriminat
52  We report the first series of Mycobacterium abscessus bacteremia after cytokine-induced killer cell
53 tibility breakpoints for M. abscessus subsp. abscessus be changed from </=2 to </=4 mug/ml and that i
54 ly effective at preventing infection with M. abscessus because it is a ubiquitous environmental sapro
55 ucible macrolide resistance in Mycobacterium abscessus but not Mycobacterium chelonae.
56 stinguishable from Mycobacterium chelonae/M. abscessus by partial 16S rRNA gene sequencing.
57 s demonstrates that the inability to type M. abscessus by PFGE is associated with a single clone of o
58  of using thiourea-containing buffer with M. abscessus by studying 69 isolates not previously typeabl
59 resistance in Mycobacterium abscessus subsp. abscessus, calling into question the usefulness of macro
60                                           M. abscessus can transition between a noninvasive, biofilm-
61 ses (57%; odds ratio = 0.7, P < 0.05) and M. abscessus cases (51%; odds ratio = 0.5, P < 0.01) than i
62                                Mycobacterium abscessus causes disease in patients with structural abn
63 tidolipid in the outermost portion of the M. abscessus cell wall masks underlying cell wall lipids in
64 s provides an explanation whereby initial M. abscessus colonization of abnormal lung airways escapes
65 hromogenicum (11 of 11), and the M. chelonae-abscessus complex (21 of 21).
66           Multi-drug resistant Mycobacterium abscessus complex (MABSC) is a form of Nontuberculous my
67 equencing (26 isolates of the M. chelonae-M. abscessus complex and 64 remaining isolates, including M
68                      Forty-one Mycobacterium abscessus complex isolates from 17 pediatric cystic fibr
69 hods differentiate between members of the M. abscessus complex.
70 farcinica, 12 N. otitidiscaviarum, and 10 N. abscessus cultures were studied.
71 cterium avium complex [MAC] or Mycobacterium abscessus) disease.
72 g susceptibility testing, all isolates of M. abscessus exhibited resistance to tobramycin (MIC of 8 t
73                                           M. abscessus exists as either a glycopeptidolipid (GPL) exp
74                               Conversely, M. abscessus expressing GPL does not stimulate expression o
75 s thought to be colonized with Mycobacterium abscessus for 13 yr prior to developing clinically appar
76                       Blood cultures grew M. abscessus for all patients, and admission peripheral blo
77 g were done on 168 consecutive isolates of M abscessus from 31 patients attending an adult cystic fib
78                            The release of M. abscessus from apoptotic macrophages initiated the forma
79 -confirmed colonization or infection with M. abscessus from January 2013 through December 2015.
80 cobacteria (RGM), particularly Mycobacterium abscessus, from individuals with cystic fibrosis (CF) is
81 is facilitated by biofilm formation, with M. abscessus glycopeptidolipids playing an important role.
82                 Members of the Mycobacterium abscessus group (MAG) cause lung, soft tissue, and disse
83 e M. avium complex (MAC), the M. chelonae-M. abscessus group (MCAG), the M. fortuitum group (MFG), an
84 bscessus (M. abscessus sensu lato, or the M. abscessus group) comprises three closely related taxa wh
85     Mycobacterium massiliense (Mycobacterium abscessus group) is an emerging pathogen causing pulmona
86 e erm(41) and rrl genes in the Mycobacterium abscessus group, a multiplex real-time PCR assay for cla
87 cation within 24 h after isolation of the M. abscessus group.
88 ugh colony morphology shift in Mycobacterium abscessus has been implicated in loss of glycopeptidolip
89                                Mycobacterium abscessus has emerged as a major pathogen in cystic fibr
90                                Mycobacterium abscessus has emerged as an important cause of lung infe
91 ncluding M. immunogenum, M. chelonae, and M. abscessus, have been associated with nosocomial infectio
92 to define the mechanisms of acquisition of M abscessus in individuals with cystic fibrosis.
93                     The incidence rate of M. abscessus increased from 0.7 cases per 10000 patient-day
94 cording in the in vivo physiopathology of M. abscessus infection and emphasizes cording as a mechanis
95 from nine non-CF patients with persistent M. abscessus infection were characterized by colony morphol
96 3 drugs usually combined for treatment of M. abscessus infection, cefoxitin was the most active becau
97      Alternative routes of acquisition of M. abscessus infection, in particular the environment, requ
98 al isolates, we show that the majority of M. abscessus infections are acquired through transmission,
99               The prognosis of Mycobacterium abscessus infections is poor due to the lack of effectiv
100 d chemical structure class active against M. abscessus infections with promising translational develo
101            The same has been observed for M. abscessus infections, which are very difficult to treat;
102  macrolides for treating M. abscessus subsp. abscessus infections.
103                                Mycobacterium abscessus is a fast-growing, multidrug-resistant organis
104                                Mycobacterium abscessus is a rapidly growing environmental mycobacteri
105                                Mycobacterium abscessus is a rapidly growing mycobacterial species whi
106                                Mycobacterium abscessus is a rapidly growing Mycobacterium causing a w
107                                Mycobacterium abscessus is an important cause of water-related nosocom
108 differentiation of these two species from M. abscessus is difficult and relies on the sequencing of o
109                                Mycobacterium abscessus is resistant to multiple antibiotics, creating
110                                Mycobacterium abscessus is the most common cause of rapidly growing my
111                           It appears that M. abscessus is transported to the CNS within macrophages.
112 activity in vitro against a wide panel of M. abscessus isolates and in infected macrophages.
113 ed whole-genome sequencing of 11 clinical M. abscessus isolates derived from eight U.S. patients with
114 -genome sequencing data demonstrated that M. abscessus isolates from 16 patients were unrelated, diff
115                                       The M. abscessus isolates from case patients and the supplement
116 Whole-genome sequencing was applied to 27 M. abscessus isolates from the 20 patients in this cohort t
117 liense and 15% to 20% of M. abscessus subsp. abscessus isolates renders these species intrinsically m
118 .S. and Western European M. abscessus subsp. abscessus isolates that are genetically distinct from ot
119   Previous population studies of clinical M. abscessus isolates utilized multilocus sequence typing o
120 d to the unambiguous identification of 26 M. abscessus isolates, 7 M. massiliense isolates, and 2 M.
121  testing by Etest of four carbapenems for M. abscessus isolates.
122 coside resistance levels of 50 Mycobacterium abscessus isolates.
123 rdonae, and 5 M. chelonae group (all were M. abscessus) isolates.
124 nd mitigated a 2-phase clonal outbreak of M. abscessus linked to hospital tap water.
125 cal to the CLSI guidelines for Mycobacterium abscessus: &lt;/=16 mug/ml for susceptible, 32 mug/ml for i
126                                Mycobacterium abscessus (M. abscessus sensu lato, or the M. abscessus
127 ough, wild-type human clinical isolate of M. abscessus (M. abscessus-R) and a smooth, attenuated muta
128 PCR for straightforward identification of M. abscessus, M. massiliense, and M. bolletii and the asses
129 ion and typing of 42 clinical isolates of M. abscessus, M. massiliense, and M. bolletii from patients
130 PCR-based method for distinguishing among M. abscessus, M. massiliense, and M. bolletii.
131 ates with ambiguous species identities as M. abscessus-M. massiliense by rpoB, hsp65, and secA sequen
132 verscores resistance and that isolates of M. abscessus/M. chelonae from CF patients are more likely t
133                                Mycobacterium abscessus (Mabs) is a rapidly growing Mycobacterium and
134 also in few samples containing Mycobacterium abscessus,Mycobacterium gordonae, o rMycobacterium therm
135 acteria (41%), fungi (10%) and Mycobacterium abscessus, Mycoplasma hominis and Lactobacillus sp. (one
136 ubsp. bolletii (n = 24), M. abscessus subsp. abscessus (n = 6), Mycobacterium fortuitum (n = 3), Myco
137 re used to identify 75 isolates as either M. abscessus or M. chelonae that were originally submitted
138  who presented with multifocal Mycobacterium abscessus osteomyelitis (patient 1) and disseminated CMV
139 ulous mycobacteria, especially Mycobacterium abscessus, post-transplantation survival has not been de
140                 We studied 118 strains of M. abscessus previously studied by PFGE by randomly amplifi
141 erved that the increased virulence of the M. abscessus R variant compared with the S variant correlat
142 ast-mycobacterium microcolony assay, with M. abscessus-R exhibiting growth characteristics similar to
143  phagocyte aggregates develop at sites of M. abscessus-R infection, but are absent with M. abscessus-
144                        We have found that M. abscessus-R is able to persist and multiply in a murine
145                                           M. abscessus-R is able to persist and multiply in human mon
146                                           M. abscessus-R resides in a phagosome typical for pathogeni
147 e human clinical isolate of M. abscessus (M. abscessus-R) and a smooth, attenuated mutant (M. abscess
148                         Recently, two new M. abscessus-related species, M. massiliense and M. bolleti
149                                       The M. abscessus rough (R) variant, devoid of cell-surface glyc
150 reported for virulent M. tuberculosis and M. abscessus-S exhibiting growth characteristics similar to
151 bscessus-R infection, but are absent with M. abscessus-S infection.
152 st and multiply in human monocytes, while M. abscessus-S is deficient in this ability.
153                              In contrast, M. abscessus-S resides in a "loose" phagosome with the phag
154 clude that a mutation has occurred in the M. abscessus-S variant which has altered the ability of thi
155 essus-R) and a smooth, attenuated mutant (M. abscessus-S) which spontaneously dissociated from the cl
156  pulmonary infection model in contrast to M. abscessus-S, which is rapidly cleared.
157                  Mycobacterium abscessus (M. abscessus sensu lato, or the M. abscessus group) compris
158 onomic statuses are under revision, i.e., M. abscessus sensu stricto, Mycobacterium bolletii, and Myc
159 cobacterium immunogenum, M. chelonae, and M. abscessus, showed various susceptibilities to the glutar
160 udy we demonstrate that rough variants of M. abscessus stimulate the human macrophage innate immune r
161 eport herein the draft genome sequence of M. abscessus strain 47J26.
162 ern) occurs with almost 50% of Mycobacterium abscessus strains during pulsed-field gel electrophoresi
163 xplores the genomic diversity of clinical M. abscessus strains from multiple continents and provides
164 om 3 confirmed infections grew Mycobacterium abscessus strains that were indistinguishable by pulsed-
165 PCR can be used for genetic comparison of M. abscessus strains, including strains which cannot be com
166 of a patient with disseminated Mycobacterium abscessus, Streptococcus viridians bacteremia, and cytom
167 erium abscessus subsp. bolletii (n = 24), M. abscessus subsp. abscessus (n = 6), Mycobacterium fortui
168 tedizolid MIC90 values for 81 isolates of M. abscessus subsp. abscessus and 12 isolates of M. abscess
169 bases accurately identified 41 Mycobacterium abscessus subsp. abscessus and 13 M. abscessus subsp. ma
170 ted the presence of two clonal groups for M. abscessus subsp. abscessus and five clonal groups for M.
171 ithromycin susceptibility breakpoints for M. abscessus subsp. abscessus be changed from </=2 to </=4
172 the usefulness of macrolides for treating M. abscessus subsp. abscessus infections.
173 ssus subsp. massiliense and 15% to 20% of M. abscessus subsp. abscessus isolates renders these specie
174 closely related U.S. and Western European M. abscessus subsp. abscessus isolates that are genetically
175             Sequencing of the erm gene of M. abscessus subsp. abscessus will predict inducible macrol
176 ucible macrolide resistance in Mycobacterium abscessus subsp. abscessus, calling into question the us
177 ing approximately 20% of U.S. isolates of M. abscessus subsp. abscessus.
178    The species identified were Mycobacterium abscessus subsp. bolletii (n = 24), M. abscessus subsp.
179 eregrinum and a nonfunctional erm gene in M. abscessus subsp. massiliense and 15% to 20% of M. absces
180 cterium abscessus subsp. abscessus and 13 M. abscessus subsp. massiliense isolates identified by whol
181 essus subsp. abscessus and 12 isolates of M. abscessus subsp. massiliense were 8 mug/ml and 4 mug/ml,
182             All 50 isolates were typed as M. abscessus subspecies abscessus and were clonally related
183 utbreaks of near-identical isolates of the M abscessus subspecies massiliense (from 11 patients), dif
184                            The clusters of M abscessus subspecies massiliense showed evidence of tran
185 ients with genetically related strains of M. abscessus that had been previously typed by variable-num
186               The intrinsic resistance of M. abscessus to most commonly available antibiotics serious
187 smear patterns were identical to those of M. abscessus type strain ATCC 19977, which had a nonsmear p
188                                      Both M. abscessus variants also have distinctive growth patterns
189 t respiratory epithelial cells respond to M. abscessus variants lacking GPL with expression of IL-8 a
190                                Mycobacterium abscessus was also isolated from respiratory specimens (
191 . abscessus, and one isolate submitted as M. abscessus was found to be M. chelonae.
192                               Previously, M. abscessus was thought to be independently acquired by su
193 y in M. chelonae), and cefoxitin (only in M. abscessus) was shown.
194  M. avium, M. mucogenicum, and Mycobacterium abscessus were found to persist most frequently.
195 ncident NTM infections from either MAC or M. abscessus were less likely to have had chronic azithromy
196 eorgica, N. asteroides, N. farcinica, and N. abscessus were only moderate resistant.
197      Several bacterial species, including M. abscessus, were cultured from an opened multidose supple
198                     Five outbreaks due to M. abscessus which gave broken DNA by PFGE gave evaluable p
199 uberculous mycobacterium (NTM) Mycobacterium abscessus, which causes progressive lung damage and is e
200 ncing of the erm gene of M. abscessus subsp. abscessus will predict inducible macrolide susceptibilit
201 ve not demonstrated cross-transmission of M. abscessus within our hospital, except between 1 sibling

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top